JP2009538330A - 塩およびその結晶変態 - Google Patents
塩およびその結晶変態 Download PDFInfo
- Publication number
- JP2009538330A JP2009538330A JP2009512241A JP2009512241A JP2009538330A JP 2009538330 A JP2009538330 A JP 2009538330A JP 2009512241 A JP2009512241 A JP 2009512241A JP 2009512241 A JP2009512241 A JP 2009512241A JP 2009538330 A JP2009538330 A JP 2009538330A
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- salt
- benzo
- dihydro
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80283606P | 2006-05-23 | 2006-05-23 | |
PCT/US2007/069327 WO2007140154A2 (fr) | 2006-05-23 | 2007-05-21 | Sels et leurs modifications cristallines |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013000196A Division JP2013075910A (ja) | 2006-05-23 | 2013-01-04 | 塩およびその結晶変態 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009538330A true JP2009538330A (ja) | 2009-11-05 |
Family
ID=38704747
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009512241A Pending JP2009538330A (ja) | 2006-05-23 | 2007-05-21 | 塩およびその結晶変態 |
JP2013000196A Withdrawn JP2013075910A (ja) | 2006-05-23 | 2013-01-04 | 塩およびその結晶変態 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013000196A Withdrawn JP2013075910A (ja) | 2006-05-23 | 2013-01-04 | 塩およびその結晶変態 |
Country Status (28)
Country | Link |
---|---|
US (1) | US7977330B2 (fr) |
EP (1) | EP2029556B1 (fr) |
JP (2) | JP2009538330A (fr) |
KR (1) | KR20090009898A (fr) |
CN (1) | CN101448796B (fr) |
AR (1) | AR061056A1 (fr) |
AT (1) | ATE486858T1 (fr) |
AU (1) | AU2007267671A1 (fr) |
BR (1) | BRPI0712556A2 (fr) |
CA (1) | CA2650514A1 (fr) |
CL (1) | CL2007001454A1 (fr) |
CR (1) | CR10431A (fr) |
DE (1) | DE602007010286D1 (fr) |
EC (1) | ECSP088900A (fr) |
ES (1) | ES2355166T3 (fr) |
GT (1) | GT200800253A (fr) |
IL (1) | IL195008A0 (fr) |
MA (1) | MA30482B1 (fr) |
MX (1) | MX2008014836A (fr) |
NO (1) | NO20085000L (fr) |
PE (1) | PE20080261A1 (fr) |
PL (1) | PL2029556T3 (fr) |
PT (1) | PT2029556E (fr) |
RU (1) | RU2008150627A (fr) |
TN (1) | TNSN08477A1 (fr) |
TW (1) | TW200815375A (fr) |
WO (1) | WO2007140154A2 (fr) |
ZA (1) | ZA200809096B (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006503054A (ja) * | 2002-09-20 | 2006-01-26 | アロー セラピューティクス リミテッド | ベンゾジアゼピン誘導体およびそれらを含有する医薬組成物 |
-
2007
- 2007-05-21 PE PE2007000619A patent/PE20080261A1/es not_active Application Discontinuation
- 2007-05-21 JP JP2009512241A patent/JP2009538330A/ja active Pending
- 2007-05-21 MX MX2008014836A patent/MX2008014836A/es not_active Application Discontinuation
- 2007-05-21 EP EP07797606A patent/EP2029556B1/fr active Active
- 2007-05-21 CN CN2007800181255A patent/CN101448796B/zh not_active Expired - Fee Related
- 2007-05-21 WO PCT/US2007/069327 patent/WO2007140154A2/fr active Application Filing
- 2007-05-21 AR ARP070102191A patent/AR061056A1/es unknown
- 2007-05-21 KR KR1020087028592A patent/KR20090009898A/ko not_active Application Discontinuation
- 2007-05-21 US US12/298,203 patent/US7977330B2/en not_active Expired - Fee Related
- 2007-05-21 CA CA002650514A patent/CA2650514A1/fr not_active Abandoned
- 2007-05-21 AU AU2007267671A patent/AU2007267671A1/en not_active Abandoned
- 2007-05-21 BR BRPI0712556-9A patent/BRPI0712556A2/pt not_active Application Discontinuation
- 2007-05-21 AT AT07797606T patent/ATE486858T1/de active
- 2007-05-21 DE DE602007010286T patent/DE602007010286D1/de active Active
- 2007-05-21 ES ES07797606T patent/ES2355166T3/es active Active
- 2007-05-21 PL PL07797606T patent/PL2029556T3/pl unknown
- 2007-05-21 PT PT07797606T patent/PT2029556E/pt unknown
- 2007-05-21 RU RU2008150627/04A patent/RU2008150627A/ru not_active Application Discontinuation
- 2007-05-22 TW TW096118228A patent/TW200815375A/zh unknown
- 2007-05-22 CL CL200701454A patent/CL2007001454A1/es unknown
-
2008
- 2008-10-23 ZA ZA200809096A patent/ZA200809096B/xx unknown
- 2008-10-30 IL IL195008A patent/IL195008A0/en unknown
- 2008-11-10 CR CR10431A patent/CR10431A/es not_active Application Discontinuation
- 2008-11-21 GT GT200800253A patent/GT200800253A/es unknown
- 2008-11-21 TN TNP2008000477A patent/TNSN08477A1/en unknown
- 2008-11-21 EC EC2008008900A patent/ECSP088900A/es unknown
- 2008-11-26 MA MA31419A patent/MA30482B1/fr unknown
- 2008-11-28 NO NO20085000A patent/NO20085000L/no not_active Application Discontinuation
-
2013
- 2013-01-04 JP JP2013000196A patent/JP2013075910A/ja not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006503054A (ja) * | 2002-09-20 | 2006-01-26 | アロー セラピューティクス リミテッド | ベンゾジアゼピン誘導体およびそれらを含有する医薬組成物 |
Non-Patent Citations (1)
Title |
---|
JPN6012018991; 最新創薬化学下巻 , 19990925, 347〜355頁 * |
Also Published As
Publication number | Publication date |
---|---|
CR10431A (es) | 2009-01-07 |
US20090163478A1 (en) | 2009-06-25 |
US7977330B2 (en) | 2011-07-12 |
WO2007140154A2 (fr) | 2007-12-06 |
MX2008014836A (es) | 2008-12-01 |
PE20080261A1 (es) | 2008-04-18 |
ECSP088900A (es) | 2008-12-30 |
IL195008A0 (en) | 2009-08-03 |
EP2029556B1 (fr) | 2010-11-03 |
MA30482B1 (fr) | 2009-06-01 |
AR061056A1 (es) | 2008-07-30 |
PL2029556T3 (pl) | 2011-04-29 |
CL2007001454A1 (es) | 2008-05-16 |
RU2008150627A (ru) | 2010-06-27 |
BRPI0712556A2 (pt) | 2013-07-02 |
JP2013075910A (ja) | 2013-04-25 |
KR20090009898A (ko) | 2009-01-23 |
ATE486858T1 (de) | 2010-11-15 |
AU2007267671A1 (en) | 2007-12-06 |
TNSN08477A1 (en) | 2010-04-14 |
DE602007010286D1 (de) | 2010-12-16 |
ES2355166T3 (es) | 2011-03-23 |
PT2029556E (pt) | 2011-01-31 |
CN101448796B (zh) | 2012-09-26 |
TW200815375A (en) | 2008-04-01 |
GT200800253A (es) | 2009-04-29 |
NO20085000L (no) | 2008-12-23 |
WO2007140154A3 (fr) | 2008-03-20 |
EP2029556A2 (fr) | 2009-03-04 |
ZA200809096B (en) | 2009-11-25 |
CN101448796A (zh) | 2009-06-03 |
CA2650514A1 (fr) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI418553B (zh) | 3-〔(2-{〔4-(己氧基羰基胺基-亞胺基-甲基)-苯胺基〕-甲基}-1-甲基-1h-苯并咪唑-5-羰基)-吡啶-2-基-胺基〕-丙酸乙酯-甲磺酸鹽及其作為藥物之用途 | |
KR101153606B1 (ko) | 아타자나비르 비술페이트 및 신규 형태의 제조 방법 | |
KR20030017569A (ko) | 카르베딜올 | |
JP2009537603A (ja) | 5−アミノ−3−(2’,3’−ジ−O−アセチル−ベータ−D−リボフラノシル)−3H−チアゾロ[4,5−d]ピリミジン−2−オンのマレイン酸塩のA型及びB型結晶形 | |
JP2006137778A (ja) | ゾルピデムヘミタートレイト | |
US9096574B2 (en) | Polymorphs of perampanel | |
JP2007514000A (ja) | テガセロッド塩基及びその塩の多形現象形 | |
JP2019523273A (ja) | ベリノスタットの多形形態、およびその調製のためのプロセス | |
JP6816036B2 (ja) | ヒストン脱アセチル化阻害剤の結晶形態 | |
JP2020517661A (ja) | 3−フェニル−4−プロピル−1−(ピリジン−2−イル)−1h−ピラゾール−5−オル塩酸塩の新規結晶形固体化合物 | |
JP5642766B2 (ja) | アデフォビルジピボキシルの新規結晶形及びその製造方法 | |
TW201829420A (zh) | [(1S)-1-[(2S,4R,5R)-5-(5-胺基-2-酮基-噻唑并[4,5-d]嘧啶-3-基)-4-羥基-四氫呋喃-2-基]丙基]乙酸酯之新穎固態形式 | |
JP6779972B2 (ja) | 呼吸器合胞体ウイルス(rsv)感染症の処置のためのn−[(3−アミノ−3−オキセタニル)メチル]−2−(2,3−ジヒドロ−1,1−ジオキシド−1,4−ベンゾチアゼピン−4(5h)−イル)−6−メチル−4−キナゾリンアミンの結晶形 | |
JP2020536940A (ja) | エダラボン塩 | |
JP2009538330A (ja) | 塩およびその結晶変態 | |
JP2006511614A (ja) | ナテグリニドの多形性形状 | |
US20230373998A1 (en) | Solid state forms of lorecivivint | |
EP1768969B1 (fr) | Mycophenolate de sodium cristallin | |
JP2004536868A (ja) | 不整脈治療用のピリダジノン誘導体の多形体塩 | |
US20070161709A1 (en) | Amorphous tamsulosin hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120417 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120717 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120904 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130104 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130228 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20130322 |